Esophagitis: Clinical Trials

376 trials for Esophagitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

202 completed, 47 unknown, 44 recruiting, 28 terminated. 85 Not applicable, 72 Phase 2, 54 Phase 3, 26 Phase 1, 24 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable85Completed 35, Unknown 14, Not yet recruiting 9, Recruiting 9, Terminated 9, Withdrawn 6, Active not recruiting 2, Enrolling by invitation 1
Phase 272Completed 46, Terminated 7, Unknown 7, Recruiting 5, Active not recruiting 3, Withdrawn 2, Enrolling by invitation 1, Suspended 1
Phase 354Completed 39, Terminated 5, Recruiting 4, Active not recruiting 3, Withdrawn 2, Unknown 1
Phase 126Completed 19, Terminated 2, Unknown 2, Withdrawn 2, Recruiting 1
Phase 424Completed 14, Unknown 4, Active not recruiting 2, Not yet recruiting 1, Recruiting 1, Terminated 1, Withdrawn 1
Early Phase 15Completed 3, Enrolling by invitation 1, Withdrawn 1

Follow Esophagitis: new trials by email Literature Review of Esophagitis trials Research Report on Esophagitis

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pilot Study of Salivary Bile Acids and Pepsin as Predictive Biomarkers of Reflux Disease After Sleeve Gastrectomy
Reflux Disease, Gastro-Esophageal, Sleeve Gastrectomy
Not yet recruitingHospital de MatarĂ³602026-12-012026-05-26
The Esophageal String Test as a Diagnostic Screening Tool for Eosinophilic Esophagitis Among Africans With Dysphagia in Mali and the United States
Esophageal string test - Dysphagia, Eosinophilic Esophagitis
Not applicableRecruitingNational Institute of Allergy and Infectious Diseases (NIAID)702026-10-262026-10-21
PPI Dosing Per CYP2C19 Genotype
CYP2C19 based dosing Proton Pump Inhibitors, Conventional proton pump inhibitor dose - Gastroesophageal Reflux Disease With Esophagitis
Phase 4Not yet recruitingUniversity of Florida2002026-10-012026-09-28
A Trial of Upadacitinib for Non-responsive Eosinophilic Esophagitis
Upadacitinib 30mg Dose, Upadacitinib Matching Placebo - EoE, Eosinophilic Esophagitis
Phase 2RecruitingUniversity of North Carolina, Chapel Hill522026-09-302026-10-06
Preoperative Predictors of Symptom Improvement After Laparoscopic Fundoplication
Laparoscopic Nissen fundoplication, Laparoscopic Toupet fundoplication - Gastroesophageal Reflux Disease, Hiatal Hernia
RecruitingMinia University4702026-09-202026-09-22
Sino-Russian Comparison of Outcomes After Proximal Gastrectomy With Double-Tract Reconstruction
Proximal gastrectomy with double-tract reconstruction - Gastric Adenocarcinoma, Adenocarcinoma of the Esophagogastric Junction
Not yet recruitingThe First Affiliated Hospital with Nanjing Medical University2502026-08-152026-09-02
Impact of Body Positioning on EndoFLIP Measurements: A Comparative Study of Supine and Left Lateral Decubitus Positions
EndoFlip - Dysphagia, Esophageal Stricture
Not applicableRecruitingJohns Hopkins University252026-07-242026-08-24
Elimination Diet Strategies and Histologic Remission in Children With Eosinophilic Gastrointestinal Disorders
Elimination Diet - Eosinophilic Gastrointestinal Disorders (EGID)
RecruitingCukurova University342026-07-012026-08-21
Using Red Light Therapy to Ease Skin Side Effects and Mouth Side Effects, in Children and Young People Aged 0 to 16 Years Old, Receiving Radiotherapy
Photobiomodulation - Radio Dermatitis, Mucositis Oral
Not applicableNot yet recruitingThe Christie NHS Foundation Trust2482026-06-012026-03-19
The DiNAM-EoE-C Study: Esophageal Distensibility and Novel Assessment of Motility in Eosinophilic Esophagitis
Eosinophilic Esophagitis (EoE), Dysphagia, Esophageal
Enrolling by invitationFondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico252026-05-012026-07-29
Trial of Partial Enteral Nutrition With Dairy Free Diet in Eosinophilic Esophagitis
Partial enteral nutrition (PEN) with dairy elimination, Dairy elimination alone - Eosinophilic Esophagitis (EoE)
Not applicableRecruitingKate Farms Inc362026-03-182026-04-16
PRospective Registry of Esophageal Motility
No intervention - Esophageal Diseases, Achalasia
RecruitingIRCCS San Raffaele100002026-03-092026-04-02
Comparison of Eohilia With Dupixent on Esophagus Diameter in Patients With Eosinophilic Esophagitis.
Dupilumab 300 MG/2 ML Subcutaneous Solution [DUPIXENT], budesonide oral suspension - Eosinophilic Esophagitis (EoE)
Early Phase 1Enrolling by invitationMayo Clinic602026-02-042026-05-04
Sling-Fiber Preservation POEM vs. Conventional POEM for Reducing Post-POEM GERD
Conventional POEM, Sling Fiber-Preserving POEM - Achalasia, Esophageal, GERD (Gastroesophageal Reflux Disease)
Not applicableNot yet recruitingUniversity of California, Irvine1202025-12-012025-10-22
A Prospective Cohort Study on Endoscopic Features of Upper Gastrointestinal Tract at High Altitude (Zaduo County)
Sedated gastroscopy - Reflux Esophagitis
RecruitingJilin University602025-12-012026-08-10
Utility of Mucosal Impedance Device in Chronic Esophageal Disorders:
MuVI Esophageal mucosal impedance testing - Gerd, Eosinophilic Esophagitis
RecruitingMedical College of Wisconsin502025-11-202026-07-27
A Study of Dupilumab in Small Children With an Allergic Condition of the Esophagus (Food Pipe): Eosinophilic Esophagitis
dupilumab - Eosinophilic Esophagitis (EoE)
Phase 3RecruitingRegeneron Pharmaceuticals202025-11-102026-09-29
A Study in Adult Participants With EoE to Evaluate Vonoprazan 20 mg Compared to Placebo After 12 Weeks and to Evaluate Vonoprazan 20 mg Up to 24 Weeks
Vonoprazan, Placebo - Eosinophilic Esophagitis
Phase 2Active not recruitingPhathom Pharmaceuticals, Inc.952025-10-302026-10-13
Natural History of Eosinophilic Esophagitis in Adult and Pediatric Population
Eosinophilic Esophagitis (EoE)
RecruitingFondazione IRCCS Policlinico San Matteo di Pavia2002025-09-012026-06-29
Surface EMG Testing on Swallowing in EoE Patients
Surface Electromyography, Fiberoptic Endoscopic Evaluation of Swallowing - Eosinophilic Esophagitis (EoE)
Active not recruitingMayo Clinic302025-08-042026-07-17

Showing 20 of 376. Sign in to see all of them.

Narrower conditions

Eosinophilic Esophagitis (234)  ·  Esophagitis, Peptic (81)  ·  Gastroesophageal Reflux (73)  ·  Deglutition Disorders (22)  ·  Eosinophilic enteropathy (18)  ·  Esophageal Diseases (17)  ·  Barrett Esophagus (14)  ·  Gastrointestinal Diseases (12)  ·  Stomach Neoplasms (12)  ·  Eosinophilia (11)  ·  Heartburn (11)  ·  Hypersensitivity (11)  ·  Food Hypersensitivity (10)  ·  Esophageal Neoplasms (9)

Broader conditions

Digestive System Diseases (368)  ·  Gastroenteritis (368)  ·  Gastrointestinal Diseases (364)  ·  Esophageal Diseases (359)  ·  Hemic and Lymphatic Diseases (234)  ·  Immune System Diseases (232)  ·  Hypersensitivity, Immediate (230)  ·  Hematologic Diseases (229)  ·  Leukocyte Disorders (229)  ·  Eosinophilia (223)  ·  Hypersensitivity (223)  ·  Intestinal Diseases (95)  ·  Stomach Diseases (93)  ·  Duodenal Diseases (87)

Interventions

Fluticasone (17)  ·  dupilumab (15)  ·  Lansoprazole (14)  ·  Esomeprazole (13)  ·  Budesonide (12)  ·  Omeprazole (11)  ·  Rabeprazole (9)  ·  Dexlansoprazole (8)  ·  Endoscopy, Digestive System (8)  ·  AK002 (6)  ·  1-(5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamine (5)  ·  APT-1011 (5)  ·  BID protein, human (4)  ·  Endoscopy (4)  ·  Pantoprazole (4)

Sponsors

Mayo Clinic (26)  ·  AstraZeneca (15)  ·  Children's Hospital Medical Center, Cincinnati (13)  ·  Takeda (13)  ·  University of North Carolina, Chapel Hill (9)  ·  University of Colorado, Denver (8)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (7)  ·  Regeneron Pharmaceuticals (7)  ·  Allakos Inc. (6)  ·  Ann & Robert H Lurie Children's Hospital of Chicago (6)  ·  Dr. Falk Pharma GmbH (5)  ·  IRCCS San Raffaele (5)  ·  Pfizer (5)  ·  Shire (5)  ·  Celgene (4)

Countries

United States (212)  ·  China (26)  ·  Canada (24)  ·  Italy (23)  ·  Japan (21)  ·  United Kingdom (21)  ·  Germany (20)  ·  Switzerland (17)  ·  Australia (16)  ·  Spain (14)  ·  Belgium (13)  ·  Netherlands (11)  ·  Poland (11)  ·  France (10)  ·  Israel (9)

Top investigators

Evan S Dellon, MD, MPH (8)  ·  Craig Paterson, MD (5)  ·  David Katzka, MD (5)  ·  Joshua B Wechsler, MD (5)  ·  Marc E Rothenberg, MD, PhD (5)  ·  Karthik Ravi, MD (4)  ·  Marc E. Rothenberg, M.D., Ph.D. (4)  ·  Calies Menard-Katcher, MD (3)  ·  Evan Dellon, MD, MPH (3)  ·  Pingsheng Hu, Ph.D (3)

Results publications

PMID 19735233, PMID 20195905, PMID 21129076, PMID 42031097, PMID 19183157, PMID 19681809, PMID 22607579, PMID 23451835, PMID 24118079, PMID 28809387, PMID 34182150, PMID 36574003, PMID 37718471, PMID 39735351, PMID 41711386, PMID 41749054, PMID 10049409, PMID 10332535, PMID 15180722, PMID 16268977, PMID 16329022, PMID 16553582, PMID 16997628, PMID 17305763, PMID 17488253, PMID 17919504, PMID 19210298, PMID 19828470, PMID 19935783, PMID 19960205, PMID 20010088, PMID 20379093, PMID 20457157, PMID 20542323, PMID 20920599, PMID 20925534, PMID 21356058, PMID 22111863, PMID 22206777, PMID 22464259, PMID 22510027, PMID 22561055, PMID 22895393, PMID 23333143, PMID 23426452, PMID 23567357, PMID 24177377, PMID 24314292, PMID 24768678, PMID 24907494

NIH funding

U54AI117804 (4), 2014 (3), 2018 (2), 2019 (2), UL1TR001082 (2), 2009 (1), 2016 (1), 2023 (1), K23DK090073 (1), K23DK129784 (1), P30CA069533 (1), P30CA072720 (1), R01CA103769 (1), R01DK063621 (1), R01DK068158 (1)